Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is a small-sized vessel systemic necrotizing vasculitis and belongs to the family of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. The involvement of central nervous system in this condition is pretty rare. Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity described for the first time by Hinchey et al. (N Engl J Med 334(8):494–500, 1996) and characterized by MRI findings of reversible subcortical vasogenic edema predominantly in the white matter of posterior cerebral lobes. There are few case reports describing the concurrence of PRES with ANCA-associated vasculitides. We describe a case of PRES in a patient with a diagnosis of EGPA with a concise review of the literature. The exact cause of this syndrome is unknown. It has been related to eclampsia, drug-induced hypertension, renal insufficiency and also to rheumatologic diseases. Endothelial injury, hypertension and immunosuppressive medications can compromise the regulation of cerebral blood flow. In ANCA-associated vasculitides, patients presenting with symptoms of PRES represent a challenge to treatment with immunosuppressive medications. However, since an inflammatory process might be implicated, judicious use of these agents along with tight control of blood pressure and a supportive therapy may contribute to the resolution of the encephalopathic syndrome treating at the same time other manifestation related to the rheumatologic disease. Larger clinical studies are warranted to optimize the management of vasculitis-associated PRES.
Similar content being viewed by others
References
Pagnoux C, Guilpain P, Guillevin L (2007) Churg–Strauss syndrome. Curr Opin Rheumatol 19(1):25–32
Pagnoux C (2010) Churg–Strauss syndrome: evolving concepts. Discov Med 9(46):243–252
Min L, Zwerling J, Ocava LC, Chen IH, Putterman C (2006) Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum 35(6):388–395
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500
Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG, Koroshetz WJ (1998) Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 51(5):1369–1376
Kastrup O, Schlamann M, Moenninghoff C, Forsting M, Goericke S (2014) Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns. Clin Neuroradiol [Epub ahead of print]
Primavera A, Audenino D, Mavilio N, Cocito L (2001) Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis 60(5):534–537
Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y, Mizoue T, Kiya K, Tanaka I (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19(4):442–444
Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodríguez-Gutiérrez R, Galarza-Delgado DA (2013) Takayasu’s arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol 32(3):409–415
Patel UV, Patel NJ (2014). Posterior reversible leukoencephalopathy syndrome as a presenting manifestation of p-ANCA-associated vasculitis. BMJ Case Rep 2014. doi:10.1136/bcr-2013-202022
Fuentes AG, Komarla A, Gomez JI (2012) Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis. Rheumatol Int 32(8):2529–2530
Tajima Y, Matsumoto A (2006) Reversible posterior leukoencephalopathy syndrome in p-ANCA-associated vasculitis. Intern Med 45(20):1169–1171
Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YW (2005) Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol 11(3):164–166
Raghavendra S, Nair MD, Chemmanam T, Krishnamoorthy T, Radhakrishnan VV, Kuruvilla A (2007) Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol 14(3):309–314
Kastrup O, Diener (2008) TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome. HCJ Neurol 255(3):452–453
Nishio M, Yoshioka K, Yamagami K, Morikawa T, Konishi Y, Hayashi N, Himuro K, Imanishi M (2008) Reversible posterior leukoencephalopathy syndrome: a possible manifestation of Wegener’s granulomatosis-mediated endothelial injury. Mod Rheumatol 18(3):309–314
Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23(6):1038–1048
Kawano H, Kimura E, Ishizaki M, Nishida Y, Matsumoto N, Yamashita T, Hirano T, Uchino M (2002) Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa. Rinsho Shinkeigaku Clin Neurol 42(10):949–953
Conflict of interest
The authors declare no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marra, A.M., Barilaro, G., Villella, V. et al. Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides. Rheumatol Int 35, 1591–1595 (2015). https://doi.org/10.1007/s00296-015-3261-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-015-3261-x